摘要
目的探讨喹诺酮抗菌药在妇科盆腔炎性疾病临床治疗中的应用效果。方法选取我院2014年3月至2016年3月收治的80例妇科盆腔炎性疾病患者,随机分为参照组与研究组,各40例。参照组患者给予氧氟沙星+灭滴灵静脉滴注治疗,研究组患者给予盐酸左氧氟沙星+灭滴灵静脉滴注治疗。比较两组患者的临床治疗效果及不良反应发生情况。结果研究组患者的治疗总有效率为95.0%,明显高于参照组的82.5%,差异有统计学意义(P<0.05)。研究组患者的不良反应总发生率为7.5%,明显低于参照组患者的17.5%,差异有统计学意义(P<0.05)。结论对妇科盆腔炎性疾病患者给予盐酸左氧氟沙星+灭滴灵静脉滴注治疗可取得良好的效果,疗效优于氧氟沙星,值得临床推广。
Objective To explore the application effect of quinolone antimierobial agents in the clinical treatment of gynecological pelvic inflammation diseases. Methods Eighty cases of patients with gynecological pelvic inflammation diseases from March 2014 to March 2016 were selected, and randomly divided into reference group and study group, with 40 cases in each group. In the reference group, patients were given intravenous infusion of ofloxacin ＋ metronidazole, and the patients in the study group were treated with levofloxaein hydrochloride ＋ metronidazole intravenous infusion. The clinical treatment effect and adverse reactions of the two groups were compared. Results The total effective rate was 95.0% in the study group, which was significantly higher than 82.5% in the reference group, the difference was statistically significant （P〈0.05）. The total incidence of adverse events in the study group was 7.5%, which was significantly lower than 17.5% in the reference group, the difference was statistically significant （P〈0.05）. Conclusion For patients with gynecological pelvic inflammatory disease, levofloxaein hydroehloride ＋ metronidazole intravenous infusion treatment can achieve good effect, and the effect of which is better than ofloxacin, it is worthy of clinical promotion.
出处
《临床医学研究与实践》
2017年第27期40-41,共2页
Clinical Research and Practice
关键词
喹诺酮抗菌药
妇科盆腔炎性疾病
盐酸左氧氟沙星
quinolone antimierobial agents
gynecological pelvic inflammation diseases
levofloxacin hydrochloride
